Press Releases

September 15, 2021

ProMIS Neurosciences to Present at the Second Annual Undruggable Leaders Forum September 15-16, 2021

September 13, 2021

ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 23rd Annual Investment Conference

Press Archives

In the News

November 4, 2020

Pharma Boardroom – Aducanumab edges closer to Potential Approval: Next up, the Advisory Committee meeting

September 23, 2020

Pharma Boardroom – Aducanumab: On the Regulatory Home Stretch in the USA

News Archives

Podcasts

Presentations

September 13, 2021

H.C. Wainwright and Co. 23rd Annual Investment Conference

August 2, 2021

ProMIS Neurosciences Presentations at 2021 Alzheimer’s Association International Conference 

Presentations Archives

Videos

September 13, 2021

H.C. Wainwright and Co. 23rd Annual Investment Conference

November 6, 2019

ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platform

August 6, 2019

Dr. James Kupiec’s update from AAIC 2019: Demonstrating Early Proof-of-Concept with Biomarkers and Focused Patient Populations

Video Archives